Inhibikase Therapeutics, Inc.
    Insider Ownership

    |
    |

    Current Insider Ownership

    Sands Capital Alternatives, Llc10% Owner
    Common Stock
    Nov 21, 2025
    13,018,965
    18.34
    26,298,309
    Sands Frank M.10% Owner
    Common Stock
    Nov 21, 2025
    13,018,965
    18.34
    26,298,309
    Sands Capital Life Sciences Pulse Fund Ii, L.P.10% Owner
    Common Stock
    Nov 21, 2025
    13,018,965
    18.34
    26,298,309
    Bellini RobertoDirector
    Common StockStock Option (right to buy)Stock Option (Right to Buy)
    Oct 21, 2024Oct 21, 2024Jun 30, 2025
    1,460,00060,000224,761
    2.060.080.32
    2,949,200121,200454,017
    Cabell ChristopherPresident & Head of R&D
    Common StockStock Option (Right to Buy)
    Feb 21, 2026Jan 5, 2026
    676,5643,101,527
    0.954.37
    1,366,6596,265,085
    Aurentz VincentDirector
    Common StockStock Option (Right to Buy)
    Feb 21, 2026Jun 30, 2025
    510,596377,030
    0.720.53
    1,031,404761,601
    Kush ArvindDirector
    Common StockStock Option (right to buy)Stock Option (Right to Buy)
    Oct 21, 2024Oct 21, 2024Jun 30, 2025
    145,00060,000224,761
    0.200.080.32
    292,900121,200454,017
    Munshi AmitDirector
    Common StockStock Option (right to buy)Stock Option (Right to Buy)
    Feb 21, 2026Oct 21, 2024Jun 30, 2025
    38,17660,000224,761
    0.050.080.32
    77,116121,200454,017
    Grint Paul CDirector
    Stock Option (right to buy)
    Jul 16, 2024
    36,667
    0.05
    74,067
    Berman Dennis NDirector
    Stock Option (Right to Buy)
    Jun 30, 2025
    1,051,192
    1.48
    2,123,408
    Mcintyre DavidChief Financial Officer
    Stock Option (Right to Buy)
    Jan 5, 2026
    2,761,858
    3.89
    5,578,953
    Iwicki Mark TChief Executive Officer
    Stock Option (Right to Buy)
    Jan 5, 2026
    12,355,546
    17.40
    24,958,203
    Freeman Roy LesterDirector
    Stock Option (right to buy)Stock Option (Right to Buy)
    Jul 16, 2024Feb 14, 2025
    36,667926,036
    0.051.30
    74,0671,870,593
    Werner Milton H.President and CEO
    Stock Option (right to buy)Stock Option (Right to Buy)
    Apr 1, 2024Jan 21, 2025
    255,00011,714,544
    0.3616.50
    515,10023,663,379
    Dion GiseleDirector
    Stock Option (right to buy)
    Jul 16, 2024
    36,667
    0.05
    74,067
    Lees-Rolfe GarthChief Financial Officer
    Stock Option (right to buy)Stock Option (Right to Buy)
    Apr 1, 2024Jan 21, 2025
    90,0001,234,931
    0.131.74
    181,8002,494,561
    Canner DavidDirector
    Stock Option (right to buy)Stock Option (Right to Buy)
    Oct 21, 2024Jun 30, 2025
    60,000224,761
    0.080.32
    121,200454,017

    Insider Trading Trends

    Insider Transactions

    Voluntary Buys vs Sells

    Historical Insider Trading (3-Years)

    10b5-1

    Munshi AmitCommon StockNoNoTransfer
    DISPOSE
    D
    		0.00-19,089038,176Feb 21, 2026
    Aurentz VincentCommon StockNoNoTransfer
    DISPOSE
    D
    		0.00-255,2990510,596Feb 21, 2026
    Cabell ChristopherCommon StockNoNoTransfer
    DISPOSE
    D
    		0.00-338,2820676,564Feb 21, 2026
    Iwicki Mark TCommon StockNoNoGrant
    ACQUIRE
    A
    		2.01+4,982,70610,015,2394,982,706Jan 5, 2026
    Mcintyre DavidCommon StockNoNoGrant
    ACQUIRE
    A
    		2.01+986,3191,982,501986,319Jan 5, 2026
    Cabell ChristopherCommon StockNoNoGrant
    ACQUIRE
    A
    		2.01+900,1171,809,235900,117Jan 5, 2026
    Sands Frank M.Common StockNoNoBuy
    ACQUIRE
    P
    		1.45+2,068,9652,999,99913,018,965Nov 21, 2025
    Sands Capital Alternatives, LlcCommon StockNoNoBuy
    ACQUIRE
    P
    		1.45+2,068,9652,999,99913,018,965Nov 21, 2025
    Sands Capital Life Sciences Pulse Fund Ii, L.P.Common StockNoNoBuy
    ACQUIRE
    P
    		1.45+2,068,9652,999,99913,018,965Nov 21, 2025
    Berman Dennis NCommon StockNoNoGrant
    ACQUIRE
    A
    		1.95+108,176210,943108,176Jun 30, 2025
    1 - 10 of 117